Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

Motzer, Robert J ; Rini, Brian I ; McDermott, David F ; Arén Frontera, Osvaldo ; Hammers, Hans J ; Carducci, Michael A ; Salman, Pamela ; Escudier, Bernard ; Beuselinck, Benoit ; Amin, Asim ; Porta, Camillo ; George, Saby ; Neiman, Victoria ; Bracarda, Sergio ; Tykodi, Scott S ; Barthélémy, Philippe ; Leibowitz-Amit, Raya ; Plimack, Elizabeth R ; Oosting, Sjoukje F ; Redman, Bruce ; Melichar, Bohuslav ; Powles, Thomas ; Nathan, Paul ; Oudard, Stéphane ; Pook, David ; Choueiri, Toni K ; Donskov, Frede ; Grimm, Marc-Oliver ; Gurney, Howard ; Heng, Daniel Y C ; Kollmannsberger, Christian K ; Harrison, Michael R ; Tomita, Yoshihiko ; Duran, Ignacio ; Grünwald, Viktor ; McHenry, M Brent ; Mekan, Sabeen ; Tannir, Nizar M

The lancet oncology, 2019-10, Vol.20 (10), p.1370-1385 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível